Best products for gum sensitivity: according to dental experts
Mild gum sensitivity might seem like a simple slight annoyance, yet it can lead to more serious issues like gum disease if left unaddressed. You can, of course, consult your dentist to pinpoint annoying gum irritation, but if you're looking for a speedier remedy, check out one of the many over-the-counter products available on the market. To help you choose the most trusted products, I asked dentists for their top recommendations on what to use at home to help ease gum sensitivity and keep your whole mouth protected.
Best toothpastes for gum sensitivity
Best mouthwashes for gum sensitivity
CloSYS Healthy Gums Mouthwash
Amazon
Mouthwashes can be a smart bet for those dealing with gum sensitivity since they penetrate deeper into gum pockets, helping reduce inflammation in areas toothbrush bristles can't reach. Rajpal said this powerful antibacterial rinse is made with the antimicrobial agent Cloralstan which, eliminates bacteria that contributes to gingivitis and bad breath. Wei also liked the Ultra Sensitive formulation of this alcohol-free mouthwash, which is pH balanced to help promote a healthy oral environment.
$14 at Amazon
$17 at Walgreens
$20 at CVS
Tom's of Maine Sea Salt Natural Mouthwash
Amazon
Saltwater rinses have long been a home remedy for alleviating oral ailments since they're said to temporarily raise the mouth's pH, making it difficult for problem-causing bacteria to thrive. They work to promote healing without irritating the sensitive membranes in the mouth. This Tom's of Maine Sea Salt mouthwash delivers the same anti-inflammatory benefits of a sea salt solution, but with a touch of mint for added freshness.
$8 $5 at Amazon
GuruNanda Fresh Breath Mouthwash
Amazon
For those with sensitive gums, Rajpal says that it might be worth trying natural products. Made without artificial ingredients, they tend to be more delicate on the gums. Rajpal liked this mouthwash from GuruNanda, which is both alcohol- and fluoride-free. Formulated with essential oils and vitamins like vitamin E — which Wei noted has properties that can help promote healthy gums and reduce sensitivity — this mouthwash is also accepted by the American Dental Association.
$8 $7 at Amazon
$12 at iHerb
Best toothbrushes and flossers for gum sensitivity
Editor Favorite Orabrush Tongue Cleaner, 2-Pack
Amazon
If you're not already tongue scraping as part of your oral health routine, it might be worth picking up this two-pack of editor-favorite and expert-approved Orabrush cleaners. Wei said tongue scraping can help remove excess bacteria and odor-causing debris, but added you should scrape gently to avoid irritating the gums at the back of the mouth. I've been a longtime fan of these Orabrush cleaners, since their long handles and large heads make it easy to clean the entire tongue comfortably in just a few swipes.
$10 $9 at Amazon
Oral-B Water Flosser Advanced Powered
Amazon
Flossing is an integral piece of any oral hygiene routine since it helps target areas along the gumline your toothbrush can't reach. Though water flossers are not a replacement for manual flossing, they're a helpful tool for easily cleaning gums and helping flush out irritants that might contribute to sensitivity. Fraundorf recommended this Oral-B Water Flosser to help deep clean and detoxify below the gumline. She added that since it's cordless, you can even take it into the shower to avoid making a mess all over your bathroom mirror.
$90 $81 at Amazon
$90 at Target
Waterpik Aquarius Water Flosser
Waterpik
Wei said water flossers can be a gentle way to clean your gums if you find they're too sensitive to withstand the pressure of manual flossing. This Waterpik Aquarius flosser squirts water in pulses to help clean between teeth and along the gumline without irritation. Choose from nearly a dozen pressure settings based on your needs and comfort level, and in just 90 seconds, this flosser will deliver a safe and effective clean. Plus, it includes seven flosser tips so multiple family members can reap the benefits of investing in this tool.
$100 $80 at Amazon
$100 $80 at Walgreens
How to choose the best product for gum sensitivity
Commonly described as tenderness or soreness in the gums, especially when brushing or flossing, gum sensitivity can also present as a burning or tingling sensation. Fraundorf said people with sensitive gums might experience discomfort while eating or drinking — especially with very hot or cold items — or experience bleeding in the mouth during regular brushing and flossing.
Though gum sensitivity might be uncomfortable, it doesn't mean you should take a break from your regular oral hygiene routine. Our experts said you should still floss daily, brush twice daily and attend regular dental cleanings, but there are some modifications you can make to your at-home routine to help better address gum sensitivity. Wei said to consider switching to a soft-bristled toothbrush or opting for an alcohol-free mouthwash to prevent irritating the gumline. While you can still brush as normal, be sure to apply gentle pressure so as to avoid further aggravating the gums and to use small circular motions to help break up plaque.
Fraundorf recommended finding products that are specifically designed for those with sensitive gums and avoiding using anything made with harsh abrasives like hydrated silica, which is often found in whitening toothpastes. She said to look for toothpastes that contain ingredients like fluoride and potassium nitrate, which help strengthen teeth and reduce overall sensitivity. Water flossers are also great tools for deeply cleaning the gums without applying excessive force. Fraundorf added that an alcohol-free and antibacterial mouthwash can also help reduce gum inflammation without further drying or irritating the mouth.
If your gum sensitivity is persistent and not improving with at-home treatments, Wei said you'll need to seek help from a dentist. Additionally, if you notice frequent bleeding or receding gums, changes in gum color or texture, loose teeth or persistent pain or discomfort in the gums, you should schedule an appointment with your dentist for a thorough evaluation.
FAQs
The following FAQs have been answered by dental experts Dr. Erin Fraundorf, Dr. Naomi Goldman, Dr. Anjali Rajpal and Dr. Michael Wei.
What causes sensitive gums?
Our experts said many factors can contribute to gum sensitivity, such as poor oral hygiene, gum recession, excessive or aggressive brushing or flossing, hormonal changes, underlying gum disease and certain acidic or spicy foods; all of which can irritate the gums.
Wei said that increased gum sensitivity can also be a side effect of some medications. Dental procedures like teeth cleanings, restorations or orthodontic treatments may also result in temporary gum sensitivity. What is the best treatment for sensitive gums?
To help soothe gum sensitivity, Fraundorf said to look for products with ingredients like fluoride to strengthen enamel and reduce sensitivity. Other ingredients that can also benefit those with sensitive gums include hydroxyapatite, which remineralizes teeth, potassium nitrate, which calms nerve activity and lessens sensitivity and chlorhexidine, which helps fight bacteria and reduce gum inflammation.
Wei added that you'll want to avoid using oral care products that contain harsh ingredients like alcohol, strong acids, abrasive substances or artificial additives, as these can further irritate and dry out the gums.
If you're looking for a more natural remedy, Wei said ingredients like aloe vera, chamomile, green tea extract, coconut oil and vitamin E also have soothing and anti-inflammatory properties that can help with gum sensitivity. You can find these ingredients formulated in certain mouthwashes and toothpaste, including some of the ones mentioned in this article.
Before using anything new, our experts recommended consulting with your dentist to ensure the products are safe and appropriate for your specific oral health needs. What is the best electric toothbrush for sensitive gums?
Goldman said the best electric toothbrush for sensitive gums is one with a pressure indicator to help stop you from brushing too hard. 'It's important to let the brush do the work for you and just guide it over your teeth, rather than brushing with it like you would a manual toothbrush,' Goldman said.
Fraundorf agreed that you can use an electric toothbrush on sensitive gums, as long as you're using the appropriate settings and attachments. Both Fraundorf and Goldman recommend the Oral-B iO electric toothbrush series for those with gum sensitivity as the brushes have both a sensitivity setting and a sensitive brush head.
Whether you're opting for an electric or a manual toothbrush, Wei and Rajpal said you want something made with soft or extra-soft bristles to minimize any further irritation to the gums.
Meet our experts
For this article, we consulted the following experts to gain their professional insights.
Why trust CNN Underscored
CNN Underscored has a team of writers and editors who have many years of experience testing, researching and recommending products, and they ensure each article is carefully edited and products are properly vetted. We talk to top experts when relevant to make certain we are testing each product accurately, recommending only the best products and considering the pros and cons of each item. For this story, associate editor Jillian Tracy consulted four dentists on the best products to help relieve gum sensitivity at home.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Abbott Laboratories (ABT): I Am Very Upset With Abbott,' Says Jim Cramer
We recently published . Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer recently discussed. Abbott Laboratories (NYSE:ABT) is a healthcare company. While it was one of Cramer's top stocks for most of this year, this show saw the CNBC TV host take a different tone. Abbott Laboratories (NYSE:ABT)'s shares fell by 8.5% in July after the firm's latest earnings results saw it warn about a massive $1 billion hit in 2025 from tariffs. Here's what Cramer said about the firm: 'I am very upset with Abbott. They're on tonight. I have supported the company for years and years. It's the diagnostic business. We'll have Robert Ford on tonight, it's not catastrophic because I like the company, long term. But, this is not, this was another thing that happened this morning that I found quite disturbing. An operating room with a doctor monitoring a patient's vital signs during surgery with a medical device. Previously, Cramer discussed Abbott Laboratories (NYSE:ABT)'s earnings before the release: 'Then one of my absolute favorite companies, medical device maker, Abbott Labs reports. And you know, I always like to tell you which companies tend to be misinterpreted in a negative way during the earnings season. Abbott's a textbook example. It bothers me, but there are always sellers who claim to be disappointed. So, if you don't own any Abbott, may I suggest that you wait to see the numbers, wait for the stock's opening, wait for the sellers to appear. Patience is a virtue with ABT.' While we acknowledge the potential of ABT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
2 Undervalued Healthcare Stocks Poised to Dominate the Next Decade
Key Points Pfizer and Novo Nordisk have underperformed the market over the past year. But both should remain major players in important areas within the pharma industry. Investors could see the two drugmakers' shares beat the market over the next decade. 10 stocks we like better than Pfizer › Pharmaceutical giants Pfizer (NYSE: PFE) and Novo Nordisk (NYSE: NVO) have lagged the market over the past year, although Pfizer's poor performance dates back much further. Though these companies have encountered challenges, there are good reasons to be bullish on their long-term prospects. Pfizer could become an even bigger player in the oncology market (the largest therapeutic area in the industry by sales) over the next decade, while Novo Nordisk will be a major player in diabetes and the fast-growing weight management space. Both could produce excellent results along the way. Here's the rundown. 1. Pfizer Pfizer's financial results haven't been great in recent years. To make matters worse, the company will face important patent cliffs by the end of the decade. One of them will be for Eliquis, an anticoagulant that is still one of its best-selling medicines. However, Pfizer has prepared for that eventuality. The company made several acquisitions and licensing deals that significantly boosted its pipeline, especially in oncology. Pfizer spent $43 billion to acquire Seagen, a smaller cancer specialist whose lineup and pipeline were impressive for a company of its size. With the financial and strategic backing of the larger company, it should yield even more key approvals in the field in the coming years. Pfizer also recently made an up-front payment of $1.25 billion to China-based 3SBio for the rights to SSGJ-707, an investigational bispecific antibody, a portion of the oncology market that's gaining traction these days. 3SBio will be eligible for commercial and regulatory milestone payments of up to $4.8 billion, not including royalties. These moves should eventually pay off for Pfizer and strengthen its position in oncology. The drugmaker plans to have eight blockbuster cancer medicines on the market by 2030, up from its current five, while doubling its reach from the current 1 million patients it serves. Of course, Pfizer isn't just a cancer play. The company's extensive pipeline should enable it to launch products in other areas and ultimately get back on track. While its shares have been lagging the market significantly, that could change in the next decade as financial results rebound thanks to its innovative efforts. Pfizer's shares look especially attractive when considering its valuation. Its forward price-to-earnings (P/E) ratio is 8.7, much lower than the healthcare sector's 15.8. From their current levels, Pfizer's shares could go on to generate excellent returns through 2035. 2. Novo Nordisk Novo Nordisk pioneered the market for weight management medicines. However, Eli Lilly seems to have taken the lead in that field, at least for now. Novo Nordisk has faced some clinical setbacks, leading to a poor performance over the trailing-12-month period. Can the company rebound and perform well in the next decade? In my view, it can, and the market may be significantly undervaluing its potential. Its sales of Wegovy, one of the top-selling anti-obesity medications, continue to grow rapidly. Novo Nordisk recently requested approval from the U.S. Food and Drug Administration for oral semaglutide (the active ingredient in Wegovy). That's good for patients who want a non-injected option, and helps counter Lilly's up-and-coming oral GLP-1 medicine, orforglipron. Elsewhere, Novo Nordisk recently started phase 3 studies for amycretin, a next-gen weight loss candidate. Amycretin is being investigated in both oral and subcutaneous formulations, and both are currently in late-stage clinical trials. The company also enhanced its pipeline through licensing deals, including one with United Biotechnology, a subsidiary of the China-based company United Laboratories International Holdings, for UBT251. This potential anti-obesity medicine mimics the actions of three gut hormones: GLP-1, GIP, and glucagon. The transaction cost Novo Nordisk an up-front payment of $200 million and up to $1.8 billion in milestone payments. Thanks to all these developments, Novo Nordisk should remain a leader in weight management in the next decade. Even though competition is mounting, no drugmaker not named Eli Lilly has a lineup or a pipeline as deep as Novo Nordisk's. Furthermore, the Denmark-based pharmaceutical leader will also continue to dominate the diabetes market, as it has done for decades. Novo Nordisk generates consistent revenue and earnings that typically grow faster than those of similarly-sized peers. Yet the stock's forward P/E is 16.7, which is slightly above the industry average. In my view, that's a bargain for a company that generates better-than-average results and has a deep pipeline in a fast-growing area -- not to mention two of the world's top 20 best-selling drugs, in Wegovy and Ozempic. For investors willing to stay the course, Novo Nordisk's future still looks incredibly bright. Should you invest $1,000 in Pfizer right now? Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Pfizer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Prosper Junior Bakiny has positions in Eli Lilly and Novo Nordisk. The Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. 2 Undervalued Healthcare Stocks Poised to Dominate the Next Decade was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
Elevance Health, Inc. (ELV): I Won't Touch It With A 10 Foot Pole, Says Jim Cramer
We recently published . Elevance Health, Inc. (NYSE:ELV) is one of the stocks Jim Cramer recently discussed. Elevance Health, Inc. (NYSE:ELV) is one of the biggest healthcare benefits companies in America. Its shares have dipped by 24% year-to-date, primarily on the back of a 19% dip in July. Elevance Health, Inc. (NYSE:ELV)'s shares fell after the firm cut its profit forecast to $30 per share from an earlier $34.15 to $34.85 per share. Here's what Cramer said about the firm: 'They missed. I think we're finally at the point where people have said, these guys are all going to keep going down so don't worry about it. Don't sell. That stock is down much less than I thought it would be. I'm not, I mean that. Like these ones, have been, when they go down, they don't just go down nine. But this thing has been down for a while. I wouldn't touch these stocks with a ten-foot pole. They're just, this is happening before they even eviscerated Medicaid. I don't think people realize that the thing in that beautiful bill was a huge gift to accelerated depreciation, a huge gift for R&D. And just a house of pain for anything Medicaid.' A medical professional working at a computer, utilizing the company's digital solutions to improve care quality for consumers. GreensKeeper Asset Management mentioned Elevance Health, Inc. (NYSE:ELV) in its Q1 2025 investor letter. Here is what the firm said: 'Rounding out our top 5 performers in Q1 were Elevance Health, Inc. (NYSE:ELV) +17.9% and Intercontinental Exchange (ICE) + 15.8%. As mentioned in the last Scorecard, we believe the sell-off in ELV over the past year has been overdone, and the stock is trading at a significant discount to our estimate of its intrinsic value. The recent rebound reflects a partial correction of that mispricing. ICE continues to perform well as a significant portion of its earnings is driven by transaction volume on its exchanges and increasing demand for financial data, both of which generally increase when panic-induced volatility hits the markets.' While we acknowledge the potential of ELV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
